Pfizer’s Vaccine Generated 10 Times More Antibodies Than Sinovac Shot, HK Study Shows

Pfizer’s Vaccine Generated 10 Times More Antibodies Than Sinovac Shot, HK Study Shows - Printable Version

+- SG Talk (https://sgtalk.net)
+-- Forum: SG Talk (https://sgtalk.net/Forum-SG-Talk)
+--- Forum: Market Talk (https://sgtalk.net/Forum-Market-Talk)
+--- Thread: Pfizer’s Vaccine Generated 10 Times More Antibodies Than Sinovac Shot, HK Study Shows (/Thread-Pfizer%E2%80%99s-Vaccine-Generated-10-Times-More-Antibodies-Than-Sinovac-Shot-HK-Study-Shows)

Pfizer’s Vaccine Generated 10 Times More Antibodies Than Sinovac Shot, HK Study Shows - forum456 - 25-09-2021

https://www.forbes.com/sites/siladityaray/2021/07/16/pfizers-covid-19-vaccine-generated-10-times-more-antibodies-than-chinas-sinovac-shot-hong-kong-study-shows/?sh=54b9ef5622b6

People who were inoculated with the Pfizer-BioNTech Covid-19 vaccine had ten times the amount of antibodies compared to those who had received the Chinese-developed Sinovac vaccine, a Hong Kong study has shown, likely offering evidence about the varying levels of protection offered by different Covid jabs

According to the study published in The Lancet, the difference in concentrations of neutralizing antibodies “could translate into substantial differences in vaccine effectiveness.”

The study was based on samples collected from 1,442 healthcare workers working in medical clinics, public and private hospitals in Hong Kong.

The recipients of the Sinovac had “similar or lower” levels of antibodies compared to patients who had been infected by Covid-19 and had managed to fight off the disease, AFP reported.

The study only looked at concentrations of neutralizing antibodies—which are not the only measure of a vaccine’s effectiveness—and did not include any data on T cells and other potential markers of protection.

The Hong Kong study and other research from around the world suggest that vaccines using the mRNA technology—like Pfizer and Moderna—may offer more robust protection against the coronavirus and its variants compared to the more traditional inactivated virus shots. However, these viral vector vaccines are considered a critical tool for vaccinating most of the world are they are both cheaper and easier to produce and store.

RE: Pfizer’s Vaccine Generated 10 Times More Antibodies Than Sinovac Shot, HK Study Shows - webinarian - 25-09-2021

mRNA is specific to certain virus. Cells act exactly as instructed.

But when it is a variant virus, the antibodies generated may not be of use. At the same time, it prevent the correct antibodies to be generated.

So it is not working properly.

.

RE: Pfizer’s Vaccine Generated 10 Times More Antibodies Than Sinovac Shot, HK Study Shows - mikeloh - 25-09-2021

Israel has REAL data to show you how ineffective P and M are!

[Image: israel.jpg]

RE: Pfizer’s Vaccine Generated 10 Times More Antibodies Than Sinovac Shot, HK Study Shows - CHAOS - 25-09-2021

(25-09-2021, 04:40 PM)forum456 Wrote: https://www.forbes.com/sites/siladityaray/2021/07/16/pfizers-covid-19-vaccine-generated-10-times-more-antibodies-than-chinas-sinovac-shot-hong-kong-study-shows/?sh=54b9ef5622b6

People who were inoculated with the Pfizer-BioNTech Covid-19 vaccine had ten times the amount of antibodies compared to those who had received the Chinese-developed Sinovac vaccine, a Hong Kong study has shown, likely offering evidence about the varying levels of protection offered by different Covid jabs

According to the study published in The Lancet, the difference in concentrations of neutralizing antibodies “could translate into substantial differences in vaccine effectiveness.”

The study was based on samples collected from 1,442 healthcare workers working in medical clinics, public and private hospitals in Hong Kong.

The recipients of the Sinovac had “similar or lower” levels of antibodies compared to patients who had been infected by Covid-19 and had managed to fight off the disease, AFP reported.

The study only looked at concentrations of neutralizing antibodies—which are not the only measure of a vaccine’s effectiveness—and did not include any data on T cells and other potential markers of protection.

The Hong Kong study and other research from around the world suggest that vaccines using the mRNA technology—like Pfizer and Moderna—may offer more robust protection against the coronavirus and its variants compared to the more traditional inactivated virus shots. However, these viral vector vaccines are considered a critical tool for vaccinating most of the world are they are both cheaper and easier to produce and store.

10 times more side effects Clapping